Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care
- Conditions
- Infection
- Registration Number
- NCT01304459
- Lead Sponsor
- Grupo de Apoio ao Adolescente e a Crianca com Cancer
- Brief Summary
Observational protocol to analyse routine vancomycin serum levels of patients under intensive care and to obtain percentage of patients that achieve therapeutic values.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Hospitalized pediatric oncology patients
- Patients under vancomycin treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie vancomycin's efficacy in pediatric oncology infections?
How does vancomycin compare to other glycopeptide antibiotics in treating ICU-acquired infections in pediatric cancer patients?
Are there specific biomarkers that correlate with therapeutic vancomycin serum concentrations in immunocompromised pediatric oncology patients?
What adverse events are associated with vancomycin use in pediatric oncology intensive care units and how are they managed?
What combination therapies with vancomycin are being explored for multidrug-resistant infections in pediatric cancer patients?
Trial Locations
- Locations (1)
Grupo de Apoio ao Adolescente e à Criança com Câncer
🇧🇷Sao Paulo, Brazil
Grupo de Apoio ao Adolescente e à Criança com Câncer🇧🇷Sao Paulo, Brazil